Search

everythinglearnresearchcommunity

for

Search:↓

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.

Scientists found out the structure of a human enzyme linked to prostate cancer and hair loss, which could help in designing drugs.

Dutasteride helps reduce heavy drinking, especially for those who drink to cope.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

Specialized ribosomes affect aging in human skin cells.

People with pattern hair loss have higher polyamine levels in the top of their head compared to the back.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Postpartum depression is linked to changes in brain chemicals, inflammation, stress, and certain genes, and can potentially be identified by markers like specific steroids, serotonin levels, and vitamin D levels.

Ursolic acid from Ochrosia elliptica leaves may help manage PCOS symptoms.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

PCOS affects women's hormones and metabolism, but can be managed with lifestyle changes and treatments.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

SVF injections improve hair growth and reduce hair loss in people with androgenic alopecia.

The meeting highlighted promising genetic treatments for male fertility issues but noted concerns about certain cancer risks and ICSI safety.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Dexamethasone increases the activity of androgen receptors in human skin cells, which may link it to certain types of hair loss.

The inhibitor affects androgen metabolism but not ovarian function.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Prostaglandin D2 increases testosterone levels in skin cells through reactive oxygen species, not enzymes, which could lead to new hair loss treatments.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Synthetic 19-norprogestins promote bone cell growth and function through their non-phenolic metabolites.

Using lidocaine before keloid injections makes the treatment more comfortable for patients.

A new gel containing minoxidil can treat hair loss effectively, potentially reducing side effects and improving treatment.